Free Trial

Unicycive Therapeutics (UNCY) Earnings Date, Estimates & Call Transcripts

Unicycive Therapeutics logo
$0.58 -0.01 (-1.35%)
As of 09:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Unicycive Therapeutics Earnings Summary

Unicycive Therapeutics issued Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.05, which topped analysts' consensus estimates of -$0.14 by $0.09. With a trailing EPS of -$0.51, Unicycive Therapeutics' earnings are expected to grow next year, from ($0.23) to ($0.08) per share.

Q1 2025 Earnings Resources

Latest Q1 2025
Earnings Date
May. 14Estimated
Consensus EPS
(May. 14)
-$0.14
Actual EPS
(May. 14)
-$0.05 Beat By $0.09
Get Unicycive Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Unicycive Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

UNCY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

UNCY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Unicycive Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.30-$0.08-$0.18
Q2 20253-$0.11-$0.07-$0.09
Q3 20253-$0.09-$0.03-$0.06
Q4 20253-$0.03$0.14$0.08
FY 2025 12 -$0.53 -$0.04 -$0.24
Q1 20261$0.27$0.27$0.27
Q2 20261$0.29$0.29$0.29
Q3 20261$0.37$0.37$0.37
Q4 20261$0.47$0.47$0.47

Unicycive Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025-$0.14-$0.05+$0.09-$0.05--
3/27/2025Q4 2024-$0.13-$0.26 -$0.13-$0.26--
8/14/2024Q2 2024-$0.23-$0.15+$0.08-$0.15--
5/13/2024Q1 2024-$0.18-$0.27 -$0.09$0.07--
3/28/2024Q4 2023-$0.18-$0.16+$0.02-$0.16--
11/14/2023Q3 2023-$0.13-$0.13--$0.13--
8/14/2023Q2 2023-$0.39-$0.29+$0.10-$0.29--

Unicycive Therapeutics Earnings - Frequently Asked Questions

Unicycive Therapeutics (NASDAQ:UNCY) last announced its quarterly earning data on Wednesday, May 14, 2025. Learn more on UNCY's earnings history.

In the previous quarter, Unicycive Therapeutics (NASDAQ:UNCY) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.09. Learn more on analysts' earnings estimate vs. UNCY's actual earnings.

Unicycive Therapeutics (NASDAQ:UNCY) has a recorded annual revenue of $680,000.00.

Unicycive Therapeutics (NASDAQ:UNCY) has a recorded net income of -$30.54 million. UNCY has generated -$0.51 earnings per share over the last four quarters.

Unicycive Therapeutics's earnings are expected to grow from ($0.23) per share to ($0.08) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:UNCY) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners